Address
Email address
improve gut health and boost immune function. Packed with fulvic acid, polyphenols, aids in restoring regular bowel movements. Solve issues like leaky gut, reflux, constipation, and diarrhoea. This patented product is backed by extensive studies and is the ultimate detox and hangover solution. This is Nordic Shilajit!
Name
GWS Biotec OÜ
Registry code
14712394
VAT number
EE102178717
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
26.04.2019 (5)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
46901 - Non-specialised wholesale trade
175 015 €
28 904 €
17%
-
1 437 878 €
0
Submitted
No tax arrears
2%
2%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Tommi Tapani Lodman 22.11.1968 (56) | 25% - 625.00 EUR | - | Direct ownership | Founder |
Aivis Vegers 14.09.1973 (51) | - | Board member | - |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Black Balance 4 Animals OÜ 16309981 | 80% - 2 000.00 EUR | - | - |
2019 12.11.2020 | 2020 01.07.2021 | 2021 19.08.2022 | 2022 06.08.2023 | 2023 17.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 10 340 € | 114 790 € | 142 095 € | 158 096 € | 175 015 € |
Net profit (loss) for the period | 2 151 € | 60 241 € | 1 290 342 € | 51 865 € | 28 904 € |
Profit Margin | 21% | 52% | 908% | 33% | 17% |
Current Assets | 35 768 € | 112 197 € | 163 376 € | 212 419 € | 214 585 € |
Fixed Assets | - | - | 1 252 000 € | 1 252 000 € | 1 252 000 € |
Total Assets | 35 768 € | 112 197 € | 1 415 376 € | 1 464 419 € | 1 466 585 € |
Current Liabilities | 31 117 € | 47 305 € | 60 142 € | 57 320 € | 28 707 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 4 651 € | 64 892 € | 1 355 234 € | 1 407 099 € | 1 437 878 € |
Employees | 0 | 0 | 0 | 0 | 0 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 48 449.39 € | 1 349.66 € | 1 458.07 € | 2 |
2023 Q4 | 64 956.93 € | 1 091.12 € | 839.64 € | 2 |
2023 Q3 | 43 699.73 € | 214.12 € | - | 2 |
2023 Q2 | 51 091.78 € | 821.98 € | - | - |
2023 Q1 | 59 834.1 € | 703.18 € | - | - |
2022 Q4 | 65 609.91 € | 97.72 € | - | - |
2022 Q3 | 56 284.77 € | 3 697.62 € | - | - |
2022 Q2 | 30 499.35 € | 616 € | - | - |
2022 Q1 | 44 466.56 € | 1 086.11 € | - | - |
2021 Q4 | 92 140.88 € | 2 649.77 € | - | - |
2021 Q3 | 37 279.33 € | 1 103.32 € | - | - |
2021 Q2 | 34 130.5 € | 1 457.39 € | - | - |
2021 Q1 | 32 844.52 € | 2 116.91 € | - | - |
2020 Q4 | 72 699.66 € | 1 573.11 € | - | - |
2020 Q3 | 11 815.83 € | 1 125.47 € | - | - |
2020 Q2 | 46 819.52 € | 406.17 € | - | - |
2020 Q1 | 9 595.89 € | 1 087.94 € | - | - |